cranswick bio limited
cranswick bio limited Company Information
Company Number
08013140
Next Accounts
Dec 2025
Shareholders
cranswick country foods plc
Group Structure
View All
Industry
Other manufacturing n.e.c.
Registered Address
crane court, hesslewood office park, hessle, HU13 0PA
Website
http://cranswick.plc.ukcranswick bio limited Estimated Valuation
Pomanda estimates the enterprise value of CRANSWICK BIO LIMITED at £0 based on a Turnover of £0 and 0.67x industry multiple (adjusted for size and gross margin).
cranswick bio limited Estimated Valuation
Pomanda estimates the enterprise value of CRANSWICK BIO LIMITED at £0 based on an EBITDA of £0 and a 4.5x industry multiple (adjusted for size and gross margin).
cranswick bio limited Estimated Valuation
Pomanda estimates the enterprise value of CRANSWICK BIO LIMITED at £10.7k based on Net Assets of £5k and 2.14x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Cranswick Bio Limited Overview
Cranswick Bio Limited is a live company located in hessle, HU13 0PA with a Companies House number of 08013140. It operates in the other manufacturing n.e.c. sector, SIC Code 32990. Founded in March 2012, it's largest shareholder is cranswick country foods plc with a 100% stake. Cranswick Bio Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Cranswick Bio Limited Health Check
There is insufficient data available to calculate a health check for Cranswick Bio Limited. Company Health Check FAQs
0 Strong
0 Regular
1 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - Cranswick Bio Limited
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Cranswick Bio Limited
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- - Cranswick Bio Limited
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- - Cranswick Bio Limited
- - Industry AVG
Employees
with 1 employees, this is below the industry average (70)
- Cranswick Bio Limited
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- Cranswick Bio Limited
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- Cranswick Bio Limited
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Cranswick Bio Limited
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- - Cranswick Bio Limited
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Cranswick Bio Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Cranswick Bio Limited
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - Cranswick Bio Limited
- - Industry AVG
CRANSWICK BIO LIMITED financials
Cranswick Bio Limited's latest turnover from March 2024 is 0 and the company has net assets of £5 thousand. According to their latest financial statements, we estimate that Cranswick Bio Limited has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 940,000 | 1,035,000 | 1,089,000 | 982,000 | 865,000 | 104,000 | ||||||
| Other Income Or Grants | ||||||||||||
| Cost Of Sales | 920,000 | 970,000 | 1,092,000 | 1,144,000 | 727,000 | 71,000 | ||||||
| Gross Profit | 20,000 | 65,000 | -3,000 | -162,000 | 138,000 | 33,000 | ||||||
| Admin Expenses | 4,000 | 3,000 | 2,000 | 4,000 | ||||||||
| Operating Profit | 16,000 | 62,000 | -5,000 | -166,000 | 138,000 | 33,000 | ||||||
| Interest Payable | ||||||||||||
| Interest Receivable | 4,000 | 3,000 | 6,000 | 4,000 | ||||||||
| Pre-Tax Profit | 20,000 | 65,000 | 1,000 | -162,000 | 138,000 | 33,000 | ||||||
| Tax | -3,000 | 26,000 | -8,000 | 34,000 | -31,000 | -8,000 | ||||||
| Profit After Tax | 17,000 | 91,000 | -7,000 | -128,000 | 107,000 | 25,000 | ||||||
| Dividends Paid | ||||||||||||
| Retained Profit | 17,000 | 91,000 | -7,000 | -128,000 | 107,000 | 25,000 | ||||||
| Employee Costs | ||||||||||||
| Number Of Employees | ||||||||||||
| EBITDA* | 16,000 | 62,000 | -5,000 | -166,000 | 138,000 | 33,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | ||||||||||||
| Intangible Assets | ||||||||||||
| Investments & Other | ||||||||||||
| Debtors (Due After 1 year) | ||||||||||||
| Total Fixed Assets | ||||||||||||
| Stock & work in progress | ||||||||||||
| Trade Debtors | 1,000 | 1,000 | 289,000 | 104,000 | ||||||||
| Group Debtors | 5,000 | 200,000 | 327,000 | 45,000 | ||||||||
| Misc Debtors | 19,000 | 15,000 | 33,000 | |||||||||
| Cash | 5,000 | 5,000 | 5,000 | 5,000 | 6,000 | 45,000 | 2,000 | 2,000 | 9,000 | 286,000 | ||
| misc current assets | ||||||||||||
| total current assets | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 6,000 | 265,000 | 345,000 | 324,000 | 54,000 | 286,000 | 104,000 |
| total assets | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 6,000 | 265,000 | 345,000 | 324,000 | 54,000 | 286,000 | 104,000 |
| Bank overdraft | ||||||||||||
| Bank loan | ||||||||||||
| Trade Creditors | ||||||||||||
| Group/Directors Accounts | 160,000 | 225,000 | 279,000 | 123,000 | 71,000 | |||||||
| other short term finances | ||||||||||||
| hp & lease commitments | ||||||||||||
| other current liabilities | 1,000 | 32,000 | 48,000 | 50,000 | 31,000 | 8,000 | ||||||
| total current liabilities | 1,000 | 160,000 | 257,000 | 327,000 | 50,000 | 154,000 | 79,000 | |||||
| loans | ||||||||||||
| hp & lease commitments | ||||||||||||
| Accruals and Deferred Income | ||||||||||||
| other liabilities | ||||||||||||
| provisions | ||||||||||||
| total long term liabilities | ||||||||||||
| total liabilities | 1,000 | 160,000 | 257,000 | 327,000 | 50,000 | 154,000 | 79,000 | |||||
| net assets | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 105,000 | 88,000 | -3,000 | 4,000 | 132,000 | 25,000 |
| total shareholders funds | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 5,000 | 105,000 | 88,000 | -3,000 | 4,000 | 132,000 | 25,000 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Operating Profit | 16,000 | 62,000 | -5,000 | -166,000 | 138,000 | 33,000 | ||||||
| Depreciation | ||||||||||||
| Amortisation | ||||||||||||
| Tax | -3,000 | 26,000 | -8,000 | 34,000 | -31,000 | -8,000 | ||||||
| Stock | ||||||||||||
| Debtors | 5,000 | -220,000 | -123,000 | 21,000 | 277,000 | 45,000 | -104,000 | 104,000 | ||||
| Creditors | ||||||||||||
| Accruals and Deferred Income | -1,000 | 1,000 | -32,000 | -16,000 | -2,000 | 19,000 | 23,000 | 8,000 | ||||
| Deferred Taxes & Provisions | ||||||||||||
| Cash flow from operations | -5,000 | 104,000 | 51,000 | -292,000 | -158,000 | 234,000 | -71,000 | |||||
| Investing Activities | ||||||||||||
| capital expenditure | ||||||||||||
| Change in Investments | ||||||||||||
| cash flow from investments | ||||||||||||
| Financing Activities | ||||||||||||
| Bank loans | ||||||||||||
| Group/Directors Accounts | -160,000 | -65,000 | -54,000 | 279,000 | -123,000 | 52,000 | 71,000 | |||||
| Other Short Term Loans | ||||||||||||
| Long term loans | ||||||||||||
| Hire Purchase and Lease Commitments | ||||||||||||
| other long term liabilities | ||||||||||||
| share issue | ||||||||||||
| interest | 4,000 | 3,000 | 6,000 | 4,000 | ||||||||
| cash flow from financing | -260,000 | -61,000 | -51,000 | 285,000 | -119,000 | 52,000 | 71,000 | |||||
| cash and cash equivalents | ||||||||||||
| cash | -5,000 | -1,000 | -39,000 | 43,000 | -7,000 | -277,000 | 286,000 | |||||
| overdraft | ||||||||||||
| change in cash | -5,000 | -1,000 | -39,000 | 43,000 | -7,000 | -277,000 | 286,000 |
cranswick bio limited Credit Report and Business Information
Cranswick Bio Limited Competitor Analysis
Perform a competitor analysis for cranswick bio limited by selecting its closest rivals, whether from the MANUFACTURING sector, other established companies, companies in HU13 area or any other competitors across 12 key performance metrics.
cranswick bio limited Ownership
CRANSWICK BIO LIMITED group structure
Cranswick Bio Limited has no subsidiary companies.
Ultimate parent company
2 parents
CRANSWICK BIO LIMITED
08013140
cranswick bio limited directors
Cranswick Bio Limited currently has 2 directors. The longest serving directors include Mr John Bottomley (May 2012) and Mr Adam Couch (Mar 2014).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr John Bottomley | England | 61 years | May 2012 | - | Director |
| Mr Adam Couch | England | 56 years | Mar 2014 | - | Director |
P&L
March 2024turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
5k
0%
total assets
5k
0%
cash
0
-1%
net assets
Total assets minus all liabilities
cranswick bio limited company details
company number
08013140
Type
Private limited with Share Capital
industry
32990 - Other manufacturing n.e.c.
incorporation date
March 2012
age
13
incorporated
UK
ultimate parent company
accounts
Audit Exemption Subsidiary
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
crane court, hesslewood office park, hessle, HU13 0PA
Bank
LLOYDS TSB BANK PLC
Legal Advisor
-
cranswick bio limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to cranswick bio limited.
cranswick bio limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CRANSWICK BIO LIMITED. This can take several minutes, an email will notify you when this has completed.
cranswick bio limited Companies House Filings - See Documents
| date | description | view/download |
|---|
